EMJ 9.1 2024

Journal Info

Spring 2024 – Volume 9, Issue 1

Contents

Congress Feature:
Non-Factor Therapies: Reflections on Current Clinical Practice
Helena Bradbury

Poster Review:
Sparsentan, a Dual Endothelin Type A and Angiotensin II Subtype 1 Receptor Antagonist for the Treatment of Immunoglobulin A Nephropathy: Latest Trial Results, Pharmacokinetic Considerations, and Binding Profile

Interviews:
Transitioning Patients From Second- to First-Line Prophylaxis in Hereditary Angioedema

Emer Kelly

Fitriana Mawardi

Kiley Whalen

Infographic:
Reviewing Advances in Bone Health

Articles:
Editor’s Pick: Patients’ Preferences for Models of Follow-Up Care During or After Initial Cancer Treatment in Greece: Development of the Qualitative Phase, and Protocol for a Discrete Choice Experiment
Stamuli et al.

Prevalence and Factors Associated with Contraceptive Use Among Females Living with HIV at Moi Teaching and Referral Hospital, Eldoret, Kenya
Sawe et al.

Renal Replacement Therapy During Liver Transplant Surgery
Sekar et al.

Staphylococcus aureus Bacteremia in Patients with Chronic Kidney Disease: Single-Centre Data from Pakistan
Moin et al.

Coexistence of Sickle Cell Thalassaemia with Overlapping Syndrome: A Case Report of Systemic Lupus Erythematosus and Autoimmune Hepatitis
Sawlani et al.

Impact of Surgical Treatment on Quality of Life of Patients with Early-Stage Cervical Cancer: A Case Study of Two Referral Hospitals in Kenya
Moseti et al.

Immunoglobin D Multiple Myeloma: A Single Centre Experience
Narayanan et al.

Membranous Nephropathy and Pulmonary Tuberculosis: An Uncommon Combination: Case Report
Bhuwania et al.

Post-endoscopic Retrograde Cholangiopancreatography Air Leak Syndrome: An Overview of Current Perspectives
Zameer et al.

Liver Elastography for the Detection of Methotrexate Induced Liver Injury: A Retrospective Study
Brotherton et al.